PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2127
https://www.valueinhealthjournal.com/article/S1098-3015(12)03841-7/fulltext
Title :
PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03841-7&doi=10.1016/j.jval.2012.08.2127
First page :
A425
Section Title :
Cancer
Open access? :
No
Section Order :
784